The Treat Now vs Monitor and Wait
Decision Flowchart
Evidence-based protocol for growing-patient timing
Master a diagnostic framework that eliminates guesswork from treatment timing decisions. Quantify space discrepancy, assess skeletal maturity, screen airway morphology, and confidently decide when to intervene and when to defer.
TL;DR A systematic treat now versus monitor and wait decision flowchart integrates growth assessment, skeletal maturity, space discrepancy quantification, and airway analysis to guide evidence-based treatment timing in mixed dentition and early adolescent cases. The flowchart prioritizes diagnostic rigor (CBCT, dental model analysis, cephalometric landmarks) before committing to active treatment.
Treatment timing remains one of the most challenging decisions in growing-patient orthodontics. Whether to intervene early with interceptive therapy, skeletal expansion, or rapid palatal expansion—or to defer treatment pending further growth—requires a systematic, evidence-based approach. In this clinical guide, Dr. Mark Radzhabov presents a comprehensive decision flowchart that integrates diagnostic protocols, growth markers, and space-analysis methods to help you determine the optimal treatment timing for each patient at ortodontmark.com. This framework is designed to reduce over-treatment, minimize patient burden, and align clinical decisions with current evidence.
What Is a Treat Now vs Monitor Flowchart?
systematic approach
A treat now versus monitor and wait decision flowchart is a systematic diagnostic protocol that integrates growth assessment, space-discrepancy quantification, skeletal maturity markers, and airway screening to determine optimal treatment timing for mixed-dentition and early-adolescent orthodontic patients. Unlike intuition-based decisions, this framework requires objective measurement at each decision point, reducing over-treatment and unnecessary burden on growing patients.
The flowchart operates on a hierarchical logic: Does the patient exhibit a genuine skeletal or dentoalveolar problem? Is the problem likely to self-correct during remaining growth? Does the severity warrant early intervention, or will growth create conditions for later successful treatment? These questions drive the sequence of diagnostic steps and the final recommendation.
Current orthodontic literature emphasizes evidence-based case selection criteria. Diagnostic tools include dental model analysis (Bolton ratios, Tanaka-Johnston predictions, arch-width measurements at Pont's and McNamara points), cephalometric assessment of skeletal maturity (cervical vertebral staging, hand-wrist radiographs), and cone-beam computed tomography (CBCT) for three-dimensional airway and skeletal relationships. Each diagnostic layer narrows the decision tree and reduces uncertainty.
The flowchart explicitly recognizes that many mixed-dentition crowding and vertical discrepancies resolve spontaneously with eruption and intercanine-width maturation. Conversely, severe anterior crossbites, significant transverse maxillary deficiency, and compromised airway anatomy often require early or surgical intervention. The framework balances these extremes with measurable thresholds.
Space Discrepancy Analysis:
The First Gate
Step one of the flowchart measures the magnitude of crowding or spacing using standardized dental model analysis. The Tanaka-Johnston index estimates the mesiodistal widths of unerupted canines and premolars using the sum of lower incisor widths, enabling accurate prediction of space needs in the mixed dentition. The Pont method relates arch width at the canine, premolar, and molar positions to mesiodistal tooth widths, identifying transverse deficiency. The McNamara tangential analysis measures the anteroposterior length of the maxillary arch and compares it to available space, quantifying sagittal deficiency.
Clinical protocol: Obtain high-resolution digital scans or stone models. Measure mesiodistal widths at the crown equator for maxillary and mandibular teeth using calipers or software (Maestro, Trios). Calculate summed lower-incisor width and apply Tanaka-Johnston regression coefficients to predict unmeshed-space needs. Compare predicted arch-length requirements to available arch length. A discrepancy ≥4 mm is considered moderate; ≥7 mm is severe.
Interpretation: A space discrepancy <3 mm often resolves with normal growth and eruption guidance. Moderate discrepancy (4–6 mm) may benefit from limited interceptive measures or monitoring. Severe discrepancy (≥7 mm) typically warrants early treatment, particularly if skeletal maturity is advanced or growth is nearly complete. This quantification shifts the decision from subjective impression to measurable criterion.
Skeletal Maturity Assessment:
Growth Remaining
The second diagnostic layer determines how much skeletal growth remains. This is critical: if significant forward-maxillary or mandibular growth is expected, treatment may be deferred or timed to coincide with the growth spurt. If skeletal maturity is advanced, early intervention becomes more urgent. Cervical vertebral staging (CVS) using lateral cephalometry is the standard; stages CS1–CS3 indicate substantial growth remaining (pre-pubertal and pubertal), while CS4–CS6 indicate declining or completed growth (post-pubertal to mature).
Hand-wrist radiographs provide additional confirmation; epiphyseal union of the distal radial physis corresponds closely with skeletal maturity. Chronological age alone is insufficient, as growth timing varies widely among children. A 12-year-old girl may be in CS5 (late pubertal), while a same-aged boy may be in CS2 (pre-pubertal). This variation profoundly affects treatment strategy.
Clinical integration: If the patient is in CS1–CS3 with moderate crowding (4–6 mm), monitoring with periodic review is defensible; natural eruption and growth may reduce crowding. If the same patient is in CS5–CS6 with moderate crowding, early comprehensive treatment or targeted interceptive therapy becomes more justified. Similarly, if the patient exhibits a Class II skeletal pattern with anterior open bite and is in CS2, timing treatment to begin during the pubertal growth spurt (CS3–CS4) maximizes skeletal correction potential. A skeletal expansion treatment timing decision should reference growth stage: expanding a patient in CS1 may be unnecessary if transverse growth is still substantial; expanding a CS5 patient is more reliably effective.
Airway and Vertical Assessment:
Systemic Health Impact
Layer three screens for airway compromise and vertical discrepancies, which influence treatment urgency. A patient with severe anterior open bite, high mandibular plane angle, and narrowed oropharyngeal airway may benefit from early skeletal expansion (via rapid palatal expansion or MARPE) to increase nasal airway volume and improve sleep-disordered breathing symptoms. Conversely, a patient with normal airway dimensions and Class I vertical relationships may safely defer treatment.
Airway assessment tools include: lateral cephalometric measurement of pharyngeal depth (PAS, posterior airway space), clinical screening for mouth breathing, sleep history, and CBCT analysis when indicated. A PAS <5 mm is considered severely restricted; 5–10 mm is narrowed; >10 mm is normal. Recent literature emphasizes that maxillary constriction often coincides with narrowed airway dimensions, creating a rationale for early miniscrew-assisted rapid palatal expansion in symptomatic patients. However, routine airway CBCT screening remains investigational; international guidelines recommend CBCT airway assessment only when clinical presentation suggests significant obstruction.
Vertical dimension is assessed via cephalometric analysis (anterior/posterior facial height ratio, mandibular plane angle) and clinical impression (openbite, deepbite, smile arc). A patient with high-angle, open-bite morphology and crowding may benefit from early extraction-based or space-creation therapy to reduce vertical strain. A low-angle, deep-bite patient with crowding may defer treatment until mixed-dentition eruption resolves mild crowding naturally. This layer prevents initiating aggressive treatment in patients whose growth trajectory will self-correct.
The Flowchart Algorithm:
Step-by-Step Logic
The flowchart begins with a single question: Is a significant orthodontic problem present? If the answer is no (mild crowding, normal overjet/overbite, normal vertical dimension, no esthetic concern), the recommendation is monitor. Return in 6–12 months.
If yes, proceed to Layer 1 (space discrepancy). If discrepancy <3 mm, move to monitoring protocol. If discrepancy ≥4 mm, proceed to Layer 2 (skeletal maturity). If CS1–CS3, consider monitoring or limited interceptive therapy (e.g., space maintenance, minor guidance). If CS4–CS6, consider comprehensive treatment or immediate interceptive therapy depending on severity and dental development stage.
For all cases with discrepancy ≥4 mm, Layer 3 (airway/vertical) applies. If airway is compromised OR vertical dimension is severely abnormal, early treatment is recommended even if crowding is modest, because the systemic/functional indication overrides growth considerations. If airway is normal and vertical dimension is acceptable, the decision defaults to space-discrepancy magnitude and skeletal maturity.
Special case: If the patient exhibits severe anterior crossbite, posterior crossbite, or eruption guidance demands (ectopic canine), early intervention is indicated regardless of space discrepancy or maturity, because dental-development sequencing justifies it. Similarly, if a patient presents with severe transverse maxillary deficiency and is in CS2–CS3, early rapid palatal expansion (RPE) timing to the pubertal growth spurt is supported. If the same patient is in CS5–CS6, miniscrew-assisted rapid palatal expansion (MARPE) becomes the indicated modality because skeletal plasticity is limited.
Case-Based Application
Real-World Examples
Case 1: 8-year-old female, 4 mm crowding, CS2, normal airway, Class I molar. Space discrepancy is mild-to-moderate. Growth potential is substantial. Recommendation: Monitor at 6-month intervals. No active treatment indicated unless eruption abnormalities emerge. Natural eruption and growth will likely reduce crowding.
Case 2: 10-year-old male, 8 mm crowding, CS3, normal airway, anterior open bite, high-angle pattern. Space discrepancy is severe. Vertical dimension is abnormal. Growth potential is moderate. Recommendation: Consider early comprehensive treatment or space-creation therapy (gentle extraction guidance, space maintenance). Timing comprehensive treatment to begin at CS4 (pubertal growth spurt) is reasonable, as mandibular growth acceleration will worsen open bite if untreated.
Case 3: 9-year-old female, 6 mm crowding, CS2, narrowed airway (PAS 7 mm), unilateral posterior crossbite. Functional/airway indication present. Space discrepancy is moderate. Growth is substantial but crossbite guidance and airway widening are priorities. Recommendation: Early rapid palatal expansion (RPE) to correct crossbite and expand palate; monitor crowding. Comprehensive treatment may be deferred until mixed-dentition eruption progresses.
Case 4: 14-year-old female, 5 mm crowding, CS5, normal airway, Class II Division 1. Growth potential is minimal. Space discrepancy is moderate. Recommendation: Comprehensive treatment should begin; deferral risks incomplete or compromised correction due to limited remaining growth. Maxillary expansion is unlikely to be skeletal (growth-dependent) at CS5, so a fixed-appliance approach with possible extraction is appropriate.
Pitfalls in Timing Decisions:
Risk Mitigation
Pitfall 1: Relying on chronological age alone. A 9-year-old may be skeletally mature (CS5) or pre-pubertal (CS1). Chronological age is a poor predictor of growth remaining. Always obtain cephalometric or hand-wrist confirmation before committing to treatment timing.
Pitfall 2: Over-treating mild discrepancies in young patients with growth potential. A 7-year-old with 2 mm crowding and CS1 does not need treatment; eruption guidance and monitoring are sufficient. Unnecessary treatment increases treatment duration, cost, and patient burden. Reserve active treatment for discrepancies ≥4 mm or specific functional indications.
Pitfall 3: Deferring treatment in skeletally mature patients. A 15-year-old in CS5 or CS6 has limited growth remaining. Deferring treatment for 2–3 years in the hope of spontaneous resolution is often futile and risks compromised final outcome. Treat now if discrepancy is moderate or severe.
Pitfall 4: Ignoring airway and vertical dimension. A patient with crowding, high-angle open bite, and airway obstruction should not be treated as a simple crowding case. Early intervention addressing vertical/airway dimensions (RPE, vertical elastics, etc.) may prevent or reduce need for future surgical correction.
Pitfall 5: Applying adult-treatment protocols to growing patients. Miniscrew-assisted rapid palatal expansion (MARPE) works well in skeletally mature patients, but in a CS2 patient with good maxillary growth potential, conventional RPE timed to the growth spurt is more efficient. Tailor the modality to the growth stage; do not default to the latest technology for every case.
Implementing the Flowchart in Your Practice
Workflow and Documentation
To operationalize the treat now versus monitor and wait flowchart, create a standardized data-collection and decision template in your electronic health record (EHR) or paper system. At the initial consultation, document: (1) chief complaint and parental expectations, (2) space-discrepancy quantification (model analysis with specific numbers), (3) skeletal-maturity assessment (CVS stage or hand-wrist finding), (4) airway screening (PAS if CBCT obtained, or clinical impression), and (5) vertical/sagittal/transverse skeletal relationships.
Then, apply the flowchart logic explicitly: “Space discrepancy is 5 mm. Growth stage is CS3. Airway is normal. Skeletal pattern is Class I. Recommendation: Monitor at 6 months; if crowding progresses to ≥7 mm or eruption disturbance appears, initiate interceptive therapy.” This transparent reasoning supports clinical decision-making and provides documentation for informed consent and communication with patients and referral sources.
For cases where early treatment is recommended, specify the modality: “Early RPE is indicated to correct bilateral posterior crossbite and expand maxilla during growth spurt (CS3). Plan to initiate treatment at next visit; expect 3–4 months of active expansion followed by retention.” For monitoring cases, schedule explicit follow-up: “Return in 6 months for reevaluation; if space discrepancy remains stable and eruption is normal, continue monitoring. If crowding worsens to >6 mm, consider early comprehensive treatment.”
Periodically audit your recommendations against outcomes. Do monitored cases with <3 mm discrepancy and CS1–CS2 maturity indeed resolve crowding spontaneously? Are early-treated cases achieving superior esthetic and functional results? Data from your own practice refines the flowchart thresholds over time and builds clinical confidence.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
At what space-discrepancy threshold should I recommend early treatment rather than monitoring in a growing patient?
Space discrepancies <3 mm often resolve with eruption and growth; monitor. Moderate discrepancy (4–6 mm) may warrant monitoring or limited interceptive therapy depending on skeletal maturity. Severe discrepancy (≥7 mm) typically indicates early treatment or comprehensive care, especially if skeletal growth is nearly complete.
How does cervical vertebral staging guide my decide-to-treat-now decision?
Cervical vertebral stages CS1–CS3 indicate substantial remaining growth; monitor mild-to-moderate problems. Stages CS4–CS6 indicate declining growth; early intervention becomes more urgent for moderate-to-severe discrepancies. CVS prevents using chronological age alone and ensures timing aligns with actual skeletal maturity.
What is the optimal timing for rapid palatal expansion in a growing patient with posterior crossbite?
Conventional RPE is most efficient during the pubertal growth spurt (CS3–CS4), when maxillary growth is accelerating and skeletal expansion potential is maximal. Early RPE (CS1–CS2) may be indicated if crossbite is functional or severe; later timing (CS5+) shifts to fixed-appliance or MARPE strategies with reduced skeletal response.
When is miniscrew-assisted rapid palatal expansion (MARPE) preferable to conventional RPE in the decision-to-treat framework?
MARPE is indicated in skeletally mature patients (CS5–CS6) or late adolescents where conventional RPE provides limited skeletal response. In younger patients with substantial growth potential, conventional RPE timed to the growth spurt is more efficient. MARPE is not a replacement for proper growth-stage assessment; tailor the modality to skeletal maturity.
How do I screen airway dimensions to inform my treat-now-or-monitor decision?
Clinical screening includes mouth-breathing history and sleep symptoms. Lateral cephalometric PAS <5 mm indicates severe restriction; 5–10 mm is narrowed. CBCT airway assessment is recommended when clinical presentation suggests obstruction or vertical/transverse discrepancies are severe. Normal airway supports deferral; compromised airway justifies early intervention.
What should I do if a patient has mild crowding (3 mm) but severe open bite and airway obstruction—should I defer or treat?
Airway and functional indicators override mild crowding in the treatment-timing decision. Early intervention addressing airway and vertical dimension (RPE, myofunctional therapy, vertical control) is justified, even if primary crowding is modest. The functional indication takes priority.
How do I document my treat-now-versus-monitor decision in the patient record to support informed consent?
Record specific measurements (space discrepancy in mm, skeletal-maturity stage, airway/vertical findings) and explicitly state the flowchart logic: “5 mm discrepancy + CS3 growth stage + normal airway = Monitor 6 months; treat if worsens.” Transparent reasoning supports compliance and medicolegal clarity.
What is the Tanaka-Johnston index and how does it guide mixed-dentition space prediction?
Tanaka-Johnston uses lower incisor width to predict unerupted canine and premolar widths, estimating total space needs in the mixed dentition. Measure lower-incisor widths, apply regression coefficients, and compare predicted needs to available arch length. Discrepancy <3 mm often resolves; ≥4 mm warrants monitoring or intervention based on maturity.
Should I obtain CBCT imaging for every growing patient to assess skeletal relationships and guide timing decisions?
No. CBCT is not routine for timing decisions. Lateral cephalometry, hand-wrist radiographs, and clinical assessment provide sufficient information for most cases. Reserve CBCT for complex vertical/transverse relationships, airway concerns, or when treatment plan hinges on 3D anatomy. Follow ALADAIP principles (indication-driven, low-dose, patient-specific).
What are the most common errors practitioners make when deciding to treat now versus monitor in growing patients, and how can I avoid them?
Common errors: relying on age alone (ignore skeletal maturity), over-treating mild crowding in young patients, deferring treatment in skeletally mature patients, ignoring airway/vertical indicators, and defaulting to adult protocols (MARPE) in young patients. Avoid by: systematically measuring discrepancy, confirming maturity stage, screening functional indicators, and matching modality to growth stage.
A structured treat now versus monitor and wait flowchart transforms subjective judgment into reproducible clinical logic. By anchoring your treatment decisions in quantified space analysis, growth assessment, and airway screening, you reduce the risk of unnecessary intervention while identifying cases that genuinely benefit from early or interceptive care. Dr. Mark Radzhabov encourages you to apply this framework in your practice and refine it with your own case data. For personalized guidance on complex timing decisions, reach out for a case review or explore Orthodontist Mark's advanced treatment planning modules.
